Literature DB >> 29203141

Interacting Cancer Machineries: Cell Signaling, Lipid Metabolism, and Epigenetics.

Thomas W Grunt1.   

Abstract

Cancer-specific perturbations of signaling, metabolism, and epigenetics can be a cause and/or consequence of malignant transformation. Evidence indicates that these regulatory systems interact with each other to form highly flexible and robust cybernetic networks that promote malignant growth and confer treatment resistance. Deciphering these plexuses using holistic approaches known from systems biology can be instructive for the future design of novel anticancer strategies. In this review, I discuss novel findings elucidating the multiple molecular interdependence among cancer-specific signaling, cell metabolism, and epigenetics to provide an insightful understanding of how major cancer machineries interact with each other during cancer development and progression, and how this knowledge may be used for future co-targeting strategies.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cancer; crosstalk; epigenetics; lipid metabolism; signaling

Mesh:

Year:  2017        PMID: 29203141     DOI: 10.1016/j.tem.2017.11.003

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  25 in total

Review 1.  The Role of Autophagy in the Resistance to BRAF Inhibition in BRAF-Mutated Melanoma.

Authors:  Xiao Liu; Jinfeng Wu; Haihong Qin; Jinhua Xu
Journal:  Target Oncol       Date:  2018-08       Impact factor: 4.493

Review 2.  Novel Insights on Lipid Metabolism Alterations in Drug Resistance in Cancer.

Authors:  Ruixue Yang; Mei Yi; Bo Xiang
Journal:  Front Cell Dev Biol       Date:  2022-05-13

3.  Prognostic nomogram integrated baseline serum lipids for patients with non-esophageal squamous cell carcinoma.

Authors:  Shulin Chen; Xiaohui Li; Xiaoyan Wen; Songguo Peng; Ning Xue; Shan Xing; Yijun Liu
Journal:  Ann Transl Med       Date:  2019-10

4.  IL-33-Induced Transcriptional Activation of LPIN1 Accelerates Breast Tumorigenesis.

Authors:  Jin-Young Kim; Garam Kim; Sung-Chul Lim; Hong-Seok Choi
Journal:  Cancers (Basel)       Date:  2021-04-30       Impact factor: 6.639

5.  PHD3 Loss Promotes Exercise Capacity and Fat Oxidation in Skeletal Muscle.

Authors:  Haejin Yoon; Jessica B Spinelli; Elma Zaganjor; Samantha J Wong; Natalie J German; Elizabeth C Randall; Afsah Dean; Allen Clermont; Joao A Paulo; Daniel Garcia; Hao Li; Olivia Rombold; Nathalie Y R Agar; Laurie J Goodyear; Reuben J Shaw; Steven P Gygi; Johan Auwerx; Marcia C Haigis
Journal:  Cell Metab       Date:  2020-07-13       Impact factor: 27.287

6.  Serum Lipidomics Profiling to Identify Biomarkers for Non-Small Cell Lung Cancer.

Authors:  Yingrong Chen; Zhihong Ma; Xiongrong Shen; Liqin Li; Jing Zhong; Li Shan Min; Limin Xu; Hongwei Li; Jianbin Zhang; Licheng Dai
Journal:  Biomed Res Int       Date:  2018-08-07       Impact factor: 3.411

Review 7.  Perturbing the Dynamics and Organization of Cell Membrane Components: A New Paradigm for Cancer-Targeted Therapies.

Authors:  Nuno Bernardes; Arsenio M Fialho
Journal:  Int J Mol Sci       Date:  2018-12-04       Impact factor: 5.923

8.  Chemical Constituents from Albiziae Cortex and Their Ability to Ameliorate Steatosis and Promote Proliferation and Anti-Oxidation In Vitro.

Authors:  Xuelin Shi; Zhongjie Li; Weiwei Cai; Yixiao Liu; Shuangshuang Li; Min Ai; Jiangnan Sun; Bao Hou; Lulu Ni; Liying Qiu
Journal:  Molecules       Date:  2019-11-07       Impact factor: 4.411

9.  Profiling circRNA and miRNA of radiation-induced esophageal injury in a rat model.

Authors:  Judong Luo; Changsong Zhang; Qiang Zhan; Fangmei An; Wenyu Zhu; Hua Jiang; Changsheng Ma
Journal:  Sci Rep       Date:  2018-10-02       Impact factor: 4.379

10.  Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells.

Authors:  Rain R Chen; Mingo M H Yung; Yang Xuan; Shijie Zhan; Leanne L Leung; Rachel R Liang; Thomas H Y Leung; Huijuan Yang; Dakang Xu; Rakesh Sharma; Karen K L Chan; Siew-Fei Ngu; Hextan Y S Ngan; David W Chan
Journal:  Commun Biol       Date:  2019-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.